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Background: Identity by descent (IBD) has played a fundamental role in the discovery of genetic loci underlying
human diseases. Both pedigree-based and population-based linkage analyses rely on estimating recent IBD, and
evidence of ancient IBD can be used to detect population structure in genetic association studies. Various methods
for detecting IBD, including those implemented in the software programs fastIBD and GERMLINE, have been
developed in the past several years using population genotype data from microarray platforms. Now, next-generation
DNA sequencing data is becoming increasingly available, enabling the comprehensive analysis of genomes, including
identifying rare variants. These sequencing data may provide an opportunity to detect IBD with higher resolution than
previously possible, potentially enabling the detection of disease causing loci that were previously undetectable with
sparser genetic data.
Results: Here, we investigate how different levels of variant coverage in sequencing and microarray genotype data
influences the resolution at which IBD can be detected. This includes microarray genotype data from the WTCCC
study, denser genotype data from the HapMap Project, low coverage sequencing data from the 1000 Genomes
Project, and deep coverage complete genome data from our own projects. With high power (78%), we can detect
segments of length 0.4 cM or larger using fastIBD and GERMLINE in sequencing data. This compares to similar
power to detect segments of length 1.0 cM or higher with microarray genotype data. We find that GERMLINE has
slightly higher power than fastIBD for detecting IBD segments using sequencing data, but also has a much higher
false positive rate.
Conclusion: We further quantify the effect of variant density, conditional on genetic map length, on the power to
resolve IBD segments. These investigations into IBD resolution may help guide the design of future next
generation sequencing studies that utilize IBD, including family-based association studies, association studies in
admixed populations, and homozygosity mapping studies.Background
The concept of identity by descent (IBD), which is used
to indicate when alleles at a given locus in two indivi-
duals are inherited from a common ancestor, has played
a fundamental role in many genetic studies. Analyses of
IBD are commonly used in pedigree data for linkage
mapping [1]. IBD also has many uses in population-
based studies, including mapping disease genes [2,3],
estimating haplotypic phase [4] and inferring evolution-
ary history (e.g., natural selection and inbreeding* Correspondence: shuyisu@gallo.ucsf.edu
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reproduction in any medium, provided the ordepression) [5,6]. More recently, IBD has been applied
to analyzing gene expression in related or unrelated indi-
viduals [7]. Incorporating such information about shared
genetic material between individuals in linkage/associ-
ation analyses has been shown to improve statistical
power for mapping disease genes in some studies [8-10].
The length of an IBD segment will depend on the
number of generations between the individuals under
study and their common ancestor, as IBD tracts are
broken down by recombination events over time. In
family data, the common ancestor is fairly recent, and
thus IBD segments are expected to be long. Long IBD
segments are easily detected with low density genotype
data; in fact, linkage analysis studies were typicallyThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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lite markers, prior to the widespread use of microarray-
based genotyping. This approach takes advantage of the
fact that tracts of IBD extend several centiMorgans (cM)
across family members, covering many genetic variants.
On the other hand, the expected length of IBD seg-
ments between two putatively unrelated subjects in a
large population is expected to be small. In this case,
deeper coverage of genetic variants obtained through se-
quencing can increase the power to detect small IBD
segments. As whole genome sequence data becomes in-
creasingly available, quantifying the extent to which se-
quence data can improve the resolution of IBD
detection is an important step toward enabling more
powerful approaches to disease gene mapping and
understanding population history.
Various methods for detecting IBD have been pro-
posed for use with population genotype data, including
methods based on observed long segments of allele shar-
ing [4,11] and on probabilities of IBD built into a hidden
Markov model (HMM) (Purcell et al., 2007; [2,12-15]).
We focus our attention on two high computationally ef-
ficient methods implemented in the software packages,
Germline [11] and fastIBD [14]. The former searches for
IBD by directly matching portions of haplotypes between
individuals from phased genotype data. The later detects
IBD segments by modeling shared haplotype frequencies
accounting for background levels of LD based on an
HMM from unphased genotype data. In addition to the
computational efficiency, fastIBD accounts for uncer-
tainty of haplotype phase while inferring IBD states. Pre-
vious studies using high-density SNP genotype data
from European ancestry samples in the HapMap project
have shown that these two programs have good power
to detect IBD segments greater than 2 cM in length [14].
Here, we conduct a comprehensive evaluation of IBD
detection using sequence data, and compare the reso-
lution of detectable IBD segment lengths with that of
microarray-based genotype data using these two soft-
ware packages (Germline and fastIBD). We investigate
the power and false positive rate of these two approaches
for microarray genotype data from the WTCCC study,
denser genotype data from the HapMap Project, low
coverage sequencing data from the 1000 Genomes Pro-
ject, and deep coverage complete genome data from our
own projects. The results of our analysis can help guide
the design of future next generation sequencing studies
that utilize IBD.
Results
In Figure 1, we present the power to detect a segment of
IBD as a function of the number of SNPs within that
segment for the five IBD segment lengths examined in
this study using the program fastIBD. The average poweracross 100 simulated datasets is shown in Table 1. Using
sequence data with high density SNP coverage improves
the power to resolve IBD segments significantly over
microarray-based genotype data, particularly for small
IBD segments. The fastIBD method is able to detect IBD
segments 0.2 cM in length with a power of 62.9% for
high coverage sequence data (Complete Genomics),
while it only has power of 12.6% for low density micro-
array genotype data (WTCCC). Power increases both as
a function of the length of the IBD segment examined
and the number of SNPs in the segment. Sequence data
provides greater numbers of SNP genotypes for the same
segment length than microarray-based genotype data.
For all four datasets, fastIBD provides good power 76.7%
to detect IBD for segments of size 1 cM and larger.
In Figure 2, we present the power to detect a segment
of IBD of as a function of the number of SNPs within
that segment for the five IBD segment lengths examined
in this study using Germline, and Table 1 shows the
average power across 100 simulated datasets. We
observed a similar trend between the power and number
of SNPs and the examined IBD segment sizes, where
Germline reports 66.5% power to detect IBD segments
of size 0.2 cM. However, Germline has poor power with
low density microarray genotype data (from WTCCC),
even for detecting large IBD segments of size 2 cM.
Comparing Germline with fastIBD, fastIBD has greater
power for low density genotype data than Germline,
whereas Germline has slightly higher power for se-
quence data.
The false positive rate (FPR) using fastIBD and Germ-
line are presented in Figures 3 and 4, respectively, as a
function of the number of SNPs within a segment. We
summarize the average FPR across 100 datasets in
Table 2. The FPR of fastIBD is low (<= 0.011) for both
low and high variant density datasets (WTCCC and
1000 Genomes projects), and lower than that of Germ-
line for sequence data (1000 Genomes data). We
observed that Germline has fairly high FPR for sequence
data, which increases linearly with the number of SNPs
within a segment.
Finally, we determined the background distribution of
IBD between subjects using all SNPs on Chromosome 1
from each of the four empirical datasets. fastIBD pro-
vides the estimated length of an IBD segment along the
chromosome, and we estimated IBD for all possible pairs
of 60 individuals (54 individuals for deep coverage se-
quence data) for each of the four datasets. We present
the distribution of IBD segment lengths in Figure 5. We
normalized the results to adjust for the different num-
bers of individuals between datasets to make the results
comparable. The deep coverage frequencies are multi-
plied by the ratio of (60 choose 2) to (54 choose 2).
Overall, the total length of IBD segments detected on
Figure 1 Empirical power of fastIBD. Empirical power of fastIBD to detect an IBD segment as a function of the number of SNPs within a
segment in the simulation study. Each plot presents different lengths of IBD segments examined. The power of each dataset is represented by
different colored circles and plotted against the number of SNPs contained within a given region.
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data is longer than that in the low variant coverage data
(Table 3), suggesting not just greater resolution but also
greater detection of IBD using sequence data. This may
be due to the fact that fastIBD is able to detect many
more small segments of size 0.5 cM or smaller with the
use of sequence data (high variant density) than that
using the low density genotype dataset.Discussion
In this study, we examined how the density of genetic
variants in a dataset affects the power to detect IBD be-
tween individuals. We found that analysis of sequence
data with high SNP density improves resolution and
power for detecting IBD relative to microarray-based
genotyping, particularly for small segments. In our simu-
lation, there was good power (80%) to detect IBD seg-
ments of size 0.4 cM using high coverage sequence data
with a low false positive rate, compared to a power ofTable 1 The average power of fastIBD and Germline
fastIBD
Segment Size (cM) WTCCC HapMap 1000 g co
0.2 0.126 0.251 0.562
0.4 0.327 0.518 0.781
0.6 0.495 0.649 0.864
1 0.767 0.840 0.904
2 0.909 0.918 0.935approximately (77%) for segments of size 1 cM using
microarray genotype data (WTCCC).
It is possible that the methods we examined in this
study may be further refined to improve the power to
detect even smaller IBD segments. We found that Germ-
line has slightly higher power to detect IBD using se-
quence data compared to fastIBD, but it has a much
higher false positive rate. That is, for high variant density
data, Germline detects many small segments, where
around 25% of them are false positives. We set the de-
tectable minimum length to 0.1 cM while running
Germline, which allows Germline be able to detect small
segments, but it increases the false positive rate. Germ-
line also provided lower power for detecting IBD seg-
ments using the microarray dataset (from WTCCC).
These results indicate that fastIBD provides more robust
and reliable IBD detection than Germline for these types
of datasets. Given these observations, the current imple-
mentation of fastIBD appears to be better than the
current implementation of Germline for detecting IBDGermline
mplete WTCCC HapMap 1000 g complete
0.629 0.043 0.344 0.665 0.645
0.801 0.099 0.551 0.836 0.806
0.874 0.135 0.617 0.901 0.907
0.899 0.231 0.794 0.941 0.944
0.919 0.389 0.905 0.982 0.992
Figure 2 Empirical power of Germline. Empirical power of Germline to detect an IBD segment as a function of the number of SNPs within a
segment in the simulation study. Each plot presents different lengths of IBD segments examined. The power of each dataset is represented by
different colored circles and plotted against the number of SNPs contained within a given region.
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note that fastIBD represents a recent update to the
HMM approach to IBD detection [2,3,13,14], and was
previously tested on microarray data.
The results of this study have important implications for
the design of genetic studies of human diseases. Identity
by descent estimation can be used to conduct family-
based association studies, association studies in admixedFigure 3 Empirical false positive rate of fastIBD. Empirical false positive
of SNPs within a segment in the simulation study. Each plot presents differ
is represented by different colored circles and plotted against the numberpopulations, and homozygosity mapping, and improved
resolution and detection of IBD can enhance the power of
these approaches to detect human disease genes. In gen-
eral, the expected length of IBD is 1/(2n) Morgans for a
common ancestor from n generations ago for a large
population, where the ancestral haplotype is transmitted
across 2n meioses. The variance of the length of an IBD
track, however, is large, and the expected IBD lengths in arate of fastIBD to detect an IBD segment as a function of the number
ent lengths of IBD segments examined. The error rate of each dataset
of SNPs contained within a given region.
Figure 4 Empirical false positive rate of Germline. Empirical false positive rate of Germline to detect an IBD segment as a function of the
number of SNPs within a segment in the simulation study. Each plot presents different lengths of IBD segments examined. The error rate of each
dataset is represented by different colored circles and plotted against the number of SNPs contained within a given region.
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by some aspects of population history (e.g., growth type
and internal subdivision) [16]. In fact, recent studies have
shown that both the amount of the genome shared identi-
cal by descent and the proportion of the genome that is
covered by long runs of homozygosity differs by popula-
tion [5,17,18]. A more detailed assessment of IBD across
populations could help determine to what extent whole
genome sequence data can improve the power of these
mapping approaches. Additionally, the continued im-
provement of IBD detection methods and the testing of
those methods on dense genetic data can provide a foun-
dation for future genetic studies.
Materials and methods
Data
To assess the statistical power to detect chromosomal seg-
ments that are shared identical by descent between two
individuals, we conducted a simulation study. First, we col-
lected genotype data from four sources that representTable 2 The average false positive rate of fastIBD and
Germline
fastIBD Germline
Segment Size (cM) WTCCC 1000 g WTCCC 1000 g
0.2 0.009 0.009 0.015 0.269
0.4 0.007 0.009 0.006 0.239
0.6 0.008 0.007 0.009 0.225
1 0.010 0.009 0.006 0.223
2 0.011 0.009 0.003 0.218different levels of coverage (that is, the proportion of all var-
iants in the genome that are assayed by a given platform),
ranging from microarray genotype data to deep coverage
whole genome sequence data. These empirical genotype
data include: Microarray genotype data (WTCCC) from the
Wellcome Trust Case Control Consortium (WTCCC)
study. We obtained genotype data on 1000 controls from
UK National Blood Donors (NBS) cohort genotyped on the
Illumina 1.2 M chip. We used the SNP set released from
the WTCCC database, which represents a cleaned set of
data from their default QC procedures [19]
Denser genotype data (HapMap) from the HapMap
phase II project. We obtained genotype data on 60 unre-
lated samples from the CEU population (Utah residents
with ancestry from northern and western Europe) Low
coverage sequence data (1000 g) from the 1000 Gen-
omes Project. We obtained genotype data on 283 indivi-
duals that originate from Europe sequenced with 4X
coverage (2010.08 release).
Deep coverage sequence data (complete) from Univer-
sity of California at San Francisco Whole Genome Se-
quencing Consortium and Complete Genomics [20]. We
obtained genotype data on 54 samples of European ori-
gin sequenced by Complete Genomics with an average
of 50X coverage. We used the Complete Genomics de-
fault cut offs for full genotype calls (excluding partial
and no calls), which pass a strict quality score metric.
Construction of artificial IBD for assessing power
Next, to investigate the power to detect IBD of various
lengths, we constructed artificial IBD segments by
Figure 5 The distribution of detected lengths of IBD segments across four investigated datasets using fastIBD. We report the counts of
detected IBD segments against estimated segment lengths on Chromosome 1 for 60 individuals in each of the datasets (54 individuals for the
deep coverage sequencing dataset).
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ual into the same location in the other individual (Fig-
ure 6). We simulated 30 pairs for WTCCC, HapMap
and 1000 g data as well as 27 pairs for the deep coverage
sequencing data, where individuals contain these artifi-
cial IBD segments for each of the datasets (a subset of
individuals from the WTCCC and 1000 Genomes pro-
jects were selected). To assure that our results were not
influenced by the structure of a single region, we ran-
domly selected 100 regions, each 3 cM in length, on
Chromosome 1, and conducted the simulation for each
of these regions separately. In each region, we created
artificial IBD segments of lengths 0.2, 0.4, 0.6, 1, and
2 cM. The program may detect several small segments
within an artificially created IBD segment. Thus, we cal-
culated the number of SNPs on these small IBD seg-
ments identified by the program. For each length of IBD
segment, power was then assessed by taking the average
proportion of SNPs that are detected as IBD within the
simulated segments, over 100 regions and 30 pairs of
individuals.Table 3 The total length (cM) of IBD segments detected
on Chromosome 1 using fastIBD
WTCCC HapMap 1000g complete
number of individuals 60 60 60 54
total length (cM) 17409 26843 29372 46936Construction of composite individuals for assessing the
false positive rate. We then investigated the rate of falsely
detecting IBD when no IBD is present through a second
simulation. We started by constructing a composite
chromosomal segment for each of 10 simulated indivi-
duals [14]. To do this, we selected 100 individuals from
the each of the WTCCC and 1000 Genomes datasets.
Composite chromosome segments of length 0.2 cM were
constructed by copying 10 consecutive regions of length
0.02 cM from 10 different individuals (Figure 7). To createFigure 6 Illustration of the procedure for creating artificial IBD
segments. For a pair of individuals, a segment of the chromosome
(shown in red) within a randomly chosen region on Chromosome 1
is copied to one chromosome in another individual.
Figure 7 Illustration of the construction of composite segments. Each line represents the chromosome sequence of an individual. The
colored circle represents the consecutive sequence of a segment size 0.02 cM, which may contain multiple SNPs. A composite segment of size
0.2 cM is composed of 10 consecutive segments of size 0.02 cM from 10 different individuals. To create a composite segment of size 0.4 cM, two
composite segments of size 0.2 cM are constructed and merged. A similar procedure is conducted to create composite segments of size 0.6, 1
and 2 cM, where three, five and ten small composite segments are constructed and merged respectively.
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and 10 consecutive composite segments. In this way, we
generated 10 simulated individuals with specific chromo-
somal segments that are not IBD. In this simulation set-
ting, we expect that any pair of these 10 individuals with
composite chromosomal segments are unlikely to share
any part of that segment longer than 0.02 cM. Thus,
detecting an IBD segment longer than 0.02 cM among
these individuals can be considered as a false positive.
As in the first simulation, we investigated 100 regions
on Chromosome 1 for each of the 5 different lengths of
composite segments (0.2, 0.4, 0.6, 1, and 2 cM). A subset
of 100 individuals from WTCCC and the 1000 Genomes
datasets were randomly selected to create the 10 com-
posite individuals. We included the other 900 individuals
in the WTCCC data and 183 individuals in the 1000
Genomes data for IBD analysis. We did not investigate
the error rate for HapMap and Complete Genomic data
due to the limited number of individuals available for
study. For each IBD segment length, the false positive
rate is calculated by the number of SNPs that are
detected as IBD divided by the total number of SNPs
within the simulated segment. The error rates were then
averaged over 100 regions and any pair of these 10 indi-
viduals. For Germline, the input data need to be phased
genotype data. Thus, we phased the data before running
Germline using fastIBD. Both fastIBD and Germline
generate a list of all pairwise IBD segments.We ran the fastIBD function in Beagle V3.3.1 with de-
fault settings. fastIBD applied a score threshold when
detecting IBD. The results in the previous study shows
that a threshold of 10−10 gives good power to detect IBD
and also keep the false discovery rate close to zero [14].
Here, we used the default threshold 10−8. We used de-
fault settings in Germline V1.5.0 except that we set the
minimum length (−min m) to 0.1 cM. This allows
Germline to have a chance of detecting small segments.
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